Intellipharmaceutics International (IPCIF) Short Interest Ratio & Short Volume → Biden replacement revealed? (From Paradigm Press) (Ad) Free IPCIF Stock Alerts $0.06 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Intellipharmaceutics International Short Interest DataCurrent Short Volume28,600 sharesPrevious Short Volume1,000 sharesChange Vs. Previous Month+2,760.00%Dollar Volume Sold Short$2,035.18Short Interest Ratio / Days to Cover1.2Last Record DateMarch 31, 2024Outstanding Shares33,090,000 sharesPercentage of Shares Shorted0.09%Today's Trading Volume5 sharesAverage Trading Volume8,183 sharesToday's Volume Vs. Average0% Short Selling Intellipharmaceutics International ? Sign up to receive the latest short interest report for Intellipharmaceutics International and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIPCIF Short Interest Over TimeIPCIF Days to Cover Over TimeIPCIF Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Intellipharmaceutics International Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202428,600 shares $2,035.18 +2,760.0%N/A1.2 $0.07 3/15/20241,000 shares $25.50 +100.0%N/A0.2 $0.03 2/29/2024500 shares $23.25 No ChangeN/A0.1 $0.05 2/15/2024500 shares $27.00 -84.9%N/A0.1 $0.05 1/15/20243,500 shares $177.45 +9.4%N/A0.2 $0.05 12/31/20233,200 shares $205.44 -61.5%N/A0.1 $0.06 Get the Latest News and Ratings for IPCIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. 12/15/20238,300 shares $605.07 +3.8%N/A1.5 $0.07 11/30/20238,000 shares $340.00 +166.7%N/A1.5 $0.04 11/15/20233,000 shares $161.40 No ChangeN/A3.8 $0.05 10/31/20233,000 shares $161.10 No ChangeN/A1.8 $0.05 10/15/20233,000 shares $210.00 No ChangeN/A0.1 $0.07 9/30/20233,000 shares $244.50 -6.3%N/A3.3 $0.08 9/15/20233,200 shares $228.80 -3.0%N/A0.6 $0.07 8/31/20233,300 shares $260.37 No ChangeN/A0.4 $0.08 8/15/20233,300 shares $312.18 +6.5%N/A0.2 $0.09 7/31/20233,100 shares $310.00 -62.7%N/A0.1 $0.10 7/15/20238,300 shares $397.57 No ChangeN/A1.4 $0.05 6/30/20238,300 shares $357.52 +1,560.0%N/A1.4 $0.04 6/15/2023500 shares $27.75 No ChangeN/A0 $0.06 5/31/2023500 shares $30.00 No ChangeN/A0.1 $0.06 5/15/2023500 shares $10.00 No ChangeN/A0 $0.02 4/30/2023500 shares $27.50 No ChangeN/A0.2 $0.06 4/15/2023500 shares $30.00 -88.9%N/A0.2 $0.06 3/31/20234,500 shares $243.23 +462.5%N/A0.3 $0.05 3/15/2023800 shares $44.80 -46.7%N/A0.2 $0.06 2/28/20231,500 shares $75.30 +7.1%N/A0.3 $0.05 2/15/20231,400 shares $85.40 +180.0%N/A0.6 $0.06 1/31/2023500 shares $37.08 No ChangeN/A0.4 $0.07 1/15/2023500 shares $44.50 No ChangeN/A0.3 $0.09 12/30/2022500 shares $35.10 -96.2%N/A0 $0.07 12/15/202213,200 shares $951.72 -5.0%N/A2.4 $0.07 11/30/202213,900 shares $1,000.80 -6.1%N/A2.3 $0.07 11/15/202214,800 shares $1,215.08 +5.7%N/A4.8 $0.08 10/31/202214,000 shares $1,142.40 +45.8%N/A2.4 $0.08 10/15/20229,600 shares $873.60 -25.6%N/A1.1 $0.09 9/30/202212,900 shares $1,056.51 -35.5%N/A1.3 $0.08 9/15/202220,000 shares $1,820.00 +29.0%N/A2.1 $0.09 8/31/202215,500 shares $1,376.40 +72.2%N/A7.8 $0.09 8/15/20229,000 shares $907.20 -71.0%N/A1.5 $0.10 7/31/202231,000 shares $3,180.60 -11.9%N/A3.2 $0.10Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here IPCIF Short Interest - Frequently Asked Questions What is Intellipharmaceutics International's current short interest? Short interest is the volume of Intellipharmaceutics International shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 28,600 shares of IPCIF short. Learn More on Intellipharmaceutics International's current short interest. What is a good short interest ratio for Intellipharmaceutics International? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPCIF shares currently have a short interest ratio of 1.0. Learn More on Intellipharmaceutics International's short interest ratio. Is Intellipharmaceutics International's short interest increasing or decreasing? Intellipharmaceutics International saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 28,600 shares, an increase of 2,760.0% from the previous total of 1,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Intellipharmaceutics International's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intellipharmaceutics International: Lipella Pharmaceuticals Inc. (1.24%), Genprex, Inc. (3.78%), Processa Pharmaceuticals, Inc. (1.56%), ZyVersa Therapeutics, Inc. (8.09%), Tharimmune, Inc. (0.65%), Artelo Biosciences, Inc. (0.45%), Ensysce Biosciences, Inc. (0.60%), Kintara Therapeutics, Inc. (1.69%), Kazia Therapeutics Limited (1.59%), Petros Pharmaceuticals, Inc. (3.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Intellipharmaceutics International stock? Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intellipharmaceutics International? A short squeeze for Intellipharmaceutics International occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPCIF, which in turn drives the price of the stock up even further. How often is Intellipharmaceutics International's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPCIF, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Lipella Pharmaceuticals Short Interest Data Genprex Short Interest Data Processa Pharmaceuticals Short Interest Data ZyVersa Therapeutics Short Interest Data Tharimmune Short Interest Data Artelo Biosciences Short Interest Data Ensysce Biosciences Short Interest Data Kintara Therapeutics Short Interest Data Kazia Therapeutics Short Interest Data Petros Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPCIF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets